Skip to main content
All lobbying filings

S-3 GROUP

Lobbying for FRESENIUS KABI · Healthcare/pharmaceutical company

 Filing 1st Quarter - Report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 21, 2025
Income
$30,000.00
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 5
  • ASHLEY DAVIS
    Previously held: Special Assistant to the Homeland Security Director, Executive Office of the President; Deputy Director of Management and Administration, Executive Office of the President
  • CRAIG KALKUT
    Previously held: Staff Director/Chief Counsel, Senate Judiciary Committee; Analyst, Senate Budget Committee; Counsel, Legislative Assistant, Special Assistant to Chief Staff, Senator Kent Conrad
  • MALLOY MCDANIEL
    Previously held: Policy Advisor, Senate Minority Leader Mitch McConnell; Whip Liaison, Senate Majority Whip Mitch McConnell; Floor Assistant, Senate Majority Leader Trent Lott; Cloakroom Assistant, Office of the Republican Secretary
  • KRISTI REMINGTON
    Previously held: Deputy Assistant Attorney General, US Department of Justice; Senior Counsel, House Government Reform Committee
  • CHRISTOPHER BUKI
    Previously held: Staff Assistant/Legislative Correspondent, Representative John Culberson; Legislative Assistant/Senior Legislative Assistant, Representative Bill Shuster; Legislative Director/Deputy Chief of Staff, Representative David McKinley

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 2
Health Issues

Issues related to drug pricing, legislation, biosimilars, patent reform, rebate reform, electronic labeling and FDA Foreign Inspection backlog

Copyright/Patent/Trademark

Issues related to drug pricing, legislation, biosimilars, patent reform, rebate reform, electronic labeling and FDA Foreign Inspection backlog

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem